Trending...
- California prioritized fighting organized retail theft, those results are paying off with 36,000 arrests and $293 million in stolen goods recovered - 104
- California and the Australian state of Queensland ink new partnership to accelerate climate resilience, agricultural technology, and innovation - 101
- California's legal cannabis market generates $8.4 billion for Californians as state cracks down on illicit operators - 101
BrightEdge, the American Cancer Society's Innovation and Impact Investment Arm, and ScaleHealth Open Applications for the 2027 BrightEdge Entrepreneurs Program
LOS ANGELES - Californer -- The dual-track program will provide cancer-focused innovators with investment, expert mentorship, education, and access to national healthcare networks
BrightEdge, the impact investment and innovation arm of the American Cancer Society (ACS), is proud to announce the opening of applications for the 2027 BrightEdge Entrepreneurs Program. In partnership with ScaleHealth, the BrightEdge Entrepreneurs program helps founders transform promising cancer-care innovations into scalable, real-world solutions.
The program brings together two specialized tracks serving companies at different points in the innovation journey:
● Digital Health: A 6-month program for companies developing technology-enabled solutions that reduce barriers and improve access to timely, high-quality cancer care.
● Life Sciences: A 10-month program supporting the translation and commercialization of therapeutic, diagnostic, and medical-device innovations that can advance cancer research and patient care.
Through financial investment, mentorship, education and connections to the American Cancer Society and ScaleHealth ecosystems, the program is designed to help founders move innovations from development toward meaningful patient impact.
"Innovation in cancer care requires more than a promising idea or technology, it requires the right expertise, resources and relationships to bring that idea into the lives of patients," said Steve Curtis, Interim Managing Director, BrightEdge. "The BrightEdge Entrepreneurs Program gives mission-driven founders the support they need to build sustainable companies while advancing solutions that can improve cancer prevention, detection, treatment and survivorship."
More on The Californer
Two Tracks Supporting Distinct Innovation Needs
The Digital Health Track seeks cancer-focused startups developing commercially viable and scalable technology solutions that can improve access, quality of life, or outcomes in cancer care. Encompassing all social drivers of health, such as transportation, financial security, and mental wellbeing, as well as direct patient care, these solutions enable access to high-quality, timely care.
Digital Health applicants should demonstrate technical feasibility, evidence of market validation and the potential to produce a measurable impact aligned with the American Cancer Society's mission. Selected companies will be eligible for a $50,000 investment, along with tailored mentorship, industry education and exposure to healthcare leaders and investors.
The Life Sciences Track supports innovators commercializing cancer-focused therapeutics, diagnostics and medical devices. It is particularly suited to technical experts embarking on their first entrepreneurial journey and committed to translating research discoveries into patient-focused companies.
Applicants to this program track do not need to have an incorporated company at the time of application. However, a company must be formed and an option or license to the underlying technology secured before the program begins. Selected Life Sciences companies will be eligible for a $100,000 investment and will receive expert-led education, individualized mentorship, stakeholder engagement and opportunities to present to curated investors.
"ScaleHealth helps connect emerging healthcare companies with the people, knowledge and opportunities required to develop, evaluate and adopt meaningful innovations," said Taylor McPartland, CEO, ScaleHealth. "Together with BrightEdge, we are creating a pathway for exceptional founders to strengthen their companies and accelerate solutions that can make a measurable difference in cancer care."
More on The Californer
Application Dates
Applications for both tracks open September 8, 2026.
● Life Sciences Track application deadline: November 2, 2026
● Digital Health Track application deadline: November 30, 2026
● Acceptance notifications and cohort announcements: February 2027 for the Life Sciences cohort and March 2027 for the Digital Health cohort.
Prospective applicants and ecosystem partners are also invited to attend "Your Guide to the BrightEdge Entrepreneurs Program," an informational webinar on Wednesday, October 7, 2026, at 9:00 a.m. PT / 12:00 p.m. ET.
The webinar will cover program eligibility, investment terms, evaluation considerations, application requirements and key deadlines. Attendees will also have an opportunity to ask questions of program leaders from BrightEdge and ScaleHealth.
To learn more and apply, visit the BrightEdge Entrepreneurs Program landing page
To register for the October 7th informational webinar, visit the webinar registration page.
About BrightEdge
BrightEdge is the innovation and impact-investment arm of the American Cancer Society. Operating at the intersection of investment and innovation, BrightEdge uses the American Cancer Society's legacy in cancer research and patient support to identify and invest in actionable, scalable solutions addressing critical unmet needs across the cancer-care continuum. Its work seeks to advance science, reduce disparities and generate sustainable impact in support of the American Cancer Society's mission. Learn more at acsbrightedge.org.
About ScaleHealth
ScaleHealth connects emerging health-technology companies with healthcare organizations, decision-makers and industry resources to help innovations develop, demonstrate value and achieve adoption. Through its marketplace, programs and advisory services, ScaleHealth supports healthcare innovators in evaluating solutions, strengthening commercialization strategies and building connections across the healthcare ecosystem. Learn more at scalehealth.com.
BrightEdge, the impact investment and innovation arm of the American Cancer Society (ACS), is proud to announce the opening of applications for the 2027 BrightEdge Entrepreneurs Program. In partnership with ScaleHealth, the BrightEdge Entrepreneurs program helps founders transform promising cancer-care innovations into scalable, real-world solutions.
The program brings together two specialized tracks serving companies at different points in the innovation journey:
● Digital Health: A 6-month program for companies developing technology-enabled solutions that reduce barriers and improve access to timely, high-quality cancer care.
● Life Sciences: A 10-month program supporting the translation and commercialization of therapeutic, diagnostic, and medical-device innovations that can advance cancer research and patient care.
Through financial investment, mentorship, education and connections to the American Cancer Society and ScaleHealth ecosystems, the program is designed to help founders move innovations from development toward meaningful patient impact.
"Innovation in cancer care requires more than a promising idea or technology, it requires the right expertise, resources and relationships to bring that idea into the lives of patients," said Steve Curtis, Interim Managing Director, BrightEdge. "The BrightEdge Entrepreneurs Program gives mission-driven founders the support they need to build sustainable companies while advancing solutions that can improve cancer prevention, detection, treatment and survivorship."
More on The Californer
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Mandeville Pests May Pose Serious Health Risks for Your Family
- xBxBio Advances Connected Cardiovascular Intelligence With Chapter 2 Release
- Share your workplace safety solutions at 2027 Applied Ergonomics Conference
- Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
Two Tracks Supporting Distinct Innovation Needs
The Digital Health Track seeks cancer-focused startups developing commercially viable and scalable technology solutions that can improve access, quality of life, or outcomes in cancer care. Encompassing all social drivers of health, such as transportation, financial security, and mental wellbeing, as well as direct patient care, these solutions enable access to high-quality, timely care.
Digital Health applicants should demonstrate technical feasibility, evidence of market validation and the potential to produce a measurable impact aligned with the American Cancer Society's mission. Selected companies will be eligible for a $50,000 investment, along with tailored mentorship, industry education and exposure to healthcare leaders and investors.
The Life Sciences Track supports innovators commercializing cancer-focused therapeutics, diagnostics and medical devices. It is particularly suited to technical experts embarking on their first entrepreneurial journey and committed to translating research discoveries into patient-focused companies.
Applicants to this program track do not need to have an incorporated company at the time of application. However, a company must be formed and an option or license to the underlying technology secured before the program begins. Selected Life Sciences companies will be eligible for a $100,000 investment and will receive expert-led education, individualized mentorship, stakeholder engagement and opportunities to present to curated investors.
"ScaleHealth helps connect emerging healthcare companies with the people, knowledge and opportunities required to develop, evaluate and adopt meaningful innovations," said Taylor McPartland, CEO, ScaleHealth. "Together with BrightEdge, we are creating a pathway for exceptional founders to strengthen their companies and accelerate solutions that can make a measurable difference in cancer care."
More on The Californer
- May The Worst Team Win! Loserball Kicks Off Another NFL Season of Hilarious Mayhem
- Wehb.pro Launches $99 AI Website Builder With No Subscription or Platform Lock-In
- Top 10 AI Trading Robots Beat Market targeting High-Margin Stocks at 155% Annualized Return for Retail Investors (NVDA, USAR)
- Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
- MainConcept Easy Video API Extends Full Transcoding to Arm and NETINT VPUs
Application Dates
Applications for both tracks open September 8, 2026.
● Life Sciences Track application deadline: November 2, 2026
● Digital Health Track application deadline: November 30, 2026
● Acceptance notifications and cohort announcements: February 2027 for the Life Sciences cohort and March 2027 for the Digital Health cohort.
Prospective applicants and ecosystem partners are also invited to attend "Your Guide to the BrightEdge Entrepreneurs Program," an informational webinar on Wednesday, October 7, 2026, at 9:00 a.m. PT / 12:00 p.m. ET.
The webinar will cover program eligibility, investment terms, evaluation considerations, application requirements and key deadlines. Attendees will also have an opportunity to ask questions of program leaders from BrightEdge and ScaleHealth.
To learn more and apply, visit the BrightEdge Entrepreneurs Program landing page
To register for the October 7th informational webinar, visit the webinar registration page.
About BrightEdge
BrightEdge is the innovation and impact-investment arm of the American Cancer Society. Operating at the intersection of investment and innovation, BrightEdge uses the American Cancer Society's legacy in cancer research and patient support to identify and invest in actionable, scalable solutions addressing critical unmet needs across the cancer-care continuum. Its work seeks to advance science, reduce disparities and generate sustainable impact in support of the American Cancer Society's mission. Learn more at acsbrightedge.org.
About ScaleHealth
ScaleHealth connects emerging health-technology companies with healthcare organizations, decision-makers and industry resources to help innovations develop, demonstrate value and achieve adoption. Through its marketplace, programs and advisory services, ScaleHealth supports healthcare innovators in evaluating solutions, strengthening commercialization strategies and building connections across the healthcare ecosystem. Learn more at scalehealth.com.
Source: ScaleHealth
Filed Under: Health
0 Comments
Latest on The Californer
- Los Angeles Massage Therapist Jesse Anoraj Places in Top Rankings at 2026 American Massage Championships
- City of Long Beach Issues Rain Advisory Due to Recent Showers
- Good Night, Oscar at North Coast Repertory Theatre
- Amaris Mint® Confirms UK Availability of Swedish-Made BioBoost Daily Nutrition Range
- 99Websites Launches \$99 Done-for-You Website Service for Busy Professionals and Small Businesses
- Yalil Guerra's "Clave" to Receive World Premiere in New Symphonic Version at The Soraya
- solar bus stop led lighting for NCTD at 18 locations
- At 70, LA Woman Launches New E-Commerce Store One Year After Nerve Damage Left Her Unable to
- AI Visibility Campaign by 1stpage Reaches 800+ Citations Across Major AI Platforms in Four Months
- Apex Lane Logistics Surpasses 100-Truck Network as Southern California Freight Capacity Expands
- xBxBio Launches Public Repository for Connected Cardiovascular Intelligence
- Hard Drive Prices Up 40 to 90 Percent Since March: eRacks Publishes Its Own Six-Month Tracking
- Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
- Governor Gavin Newsom on California securing massive victory for democracy
- Della continues to shine with her new release, Now Breathe featuring Angel Sessions
- Citrus Heights-Based Antgava Focuses on Realistic Results in Upholstery Cleaning
- City of Long Beach to Hold Moment of Silence in Remembrance of 9/11 Terrorist Attacks
- Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million
- Pervaziv AI Introduces Smarter Context Compaction in Cortex, Advancing Reliable Long Running Enterprise AI
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!